How the $2,000 Drug Cap Saves Medicare Retirees This Year
Medicare’s new $2,000 out-of-pocket cap on Part D drugs is delivering real relief for retirees, with insulin costs ca...
We evaluate long-term return potential across index funds to help you identify candidates with the strongest growth prospects.
28,522 articlesMedicare’s new $2,000 out-of-pocket cap on Part D drugs is delivering real relief for retirees, with insulin costs ca...
Saudi Aramco posts a 25% year-over-year rise in quarterly profit, supported by higher exports via the East-West Pipel...
Virgin Galactic surges 14% as SpaceX IPO buzz lifts space stocks. Rocket Lab also gains, while investors weigh the IP...
Cardano rolled out a major scaling testnet this week, aiming to boost throughput amid mixed market signals. ADA trade...
Bitcoin is moving independently of the Nasdaq as liquidity conditions tighten, a rare divergence that traders say cou...
ZachXBT has named Axiom in a probe over alleged insider trading by an employee. Axiom paused internal tools and says ...
Hewlett Packard Enterprise faces a pivotal Q2 print after the market closes, with an AI backlog fueling optimism and ...
When a company's CFO sells a chunk of shares, investors want to know what it means. This guide explains the implicati...
IonQ posted full-year revenue of $130 million and a 2026 guidance of $225-245 million, as it leans on defense contrac...
Rental-focused development dominated Q4 2025, with 91,000 rental starts among 96,000 total multifamily starts, a jump...
Bitcoin topped near $82,400 on May 20, 2026, then pulled back to around $76,000 after hitting a closely watched chart...
A landmark, independent study finds racial disparities in AI-driven hiring tools used by major employers, affecting B...